Quick answer: District of Columbia enforces strict Corporate Practice of Medicine (CPOM) requirements. Non-physicians cannot own or control clinical decisions. Nurse practitioners have full practice authority. Telehealth is permitted, with no mandatory in-person visit for new patients.
Comprehensive regulatory framework for operating telehealth, medspa, IV therapy, and healthcare services in District of Columbia (DC). This page is actively monitored for regulatory changes.
Regulatory Information Disclaimer
The telehealth compliance information for District of Columbia presented on this page is provided for general informational purposes only and should not be construed as legal advice. The telehealth regulatory landscape is evolving rapidly, with state legislatures, medical boards, and federal agencies frequently updating rules, guidance, and enforcement priorities. While TrueEval makes every effort to keep this information current and accurate, we cannot guarantee that all details reflect the very latest regulatory changes at the time of your visit.
We strongly recommend consulting with a qualified healthcare attorney or compliance professional before making business decisions based on this information. For the most current regulatory requirements, refer directly to your state medical board and relevant licensing authorities. Last reviewed: February 2026.
The District of Columbia does not have a single freestanding Corporate Practice of Medicine statute, but its Professional Corporation Act functions as one of the strictest ownership regimes in the country. DC Code § 29-508 requires that every shareholder, director, and specified officer (board chair, president, vice-president, treasurer, secretary) of a medical professional corporation be an individual licensed to render that professional service — meaning a medical PC must be 100% physician-owned and physician-governed. DC Code § 29-511 further limits share transfers to licensed individuals or the corporation itself, closing off any path to non-physician equity. Regulators and courts also apply a 'control test' (interference with clinical judgment, deriving profit from medical services, commercialization of medicine) consistent with strict CPOM jurisdictions like California and New York. A carefully structured PC-MSO arrangement — a physician-owned clinical PC/PLLC paired with a separately owned management services organization limited to non-clinical functions — remains the standard path for telehealth and medspa operators, but the MSO cannot hold equity in, or exert clinical control over, the licensed entity.
A provider-patient relationship may be established via telehealth in DC without a prior in-person visit, provided the encounter satisfies DC Board of Medicine standards, including an appropriate patient evaluation sufficient to support a diagnosis (17 DCMR § 4618.3–.4). Prescribing based solely on a static online questionnaire, without an interactive evaluation, does not meet this standard. Real-time audio or audio-video communication is expected when no prior provider-patient relationship exists. Providers must hold a DC medical license to treat DC patients, subject to narrow telehealth exceptions for out-of-jurisdiction licensees under DC Code § 3-1201.05.
Federal law (the Ryan Haight Act) generally requires a prior in-person medical evaluation before prescribing controlled substances via telehealth, unless a DEA-recognized exception applies. DEA has repeatedly extended pandemic-era telemedicine flexibilities allowing Schedule II-V prescribing via real-time audio-video telemedicine without a prior in-person exam, and as of this writing those flexibilities remain in effect through December 31, 2026 — subject to DEA registration, review of DC's Prescription Drug Monitoring Program, and a legitimate medical purpose. DC does not appear to layer additional state-specific restrictions on top of these federal rules, but providers should confirm current DEA guidance before relying on telehealth-only controlled-substance prescribing; audio-only (non-video) prescribing of controlled substances is generally limited to buprenorphine/opioid-use-disorder treatment under federal safeguards.
Because DC's professional corporation rules require the clinical entity to be 100% physician-owned, medspas, IV therapy clinics, and similar brick-and-mortar operations offering medical services (injectables, IV infusions, prescription-strength treatments) generally need a DC-licensed physician functioning as medical director — approving clinical protocols, supervising staff, and maintaining oversight of prescribing and controlled-substance handling. This is a practical consequence of DC's ownership statute rather than a standalone 'medical director' requirement.
The Health Occupations Revision General Amendment Act (B25-0545, enacted 2023–2024) repealed DC's collaboration and protocol requirements for advanced practice registered nurses (former DC Code § 3-1206.03), granting nurse practitioners full, independent practice authority. NPs in DC may evaluate, diagnose, prescribe within their certification and DEA registration, and manage treatment without a mandatory collaborating or supervising physician. DC Code §§ 3-1206.01–.04 and § 3-1206.07a govern APRN and certified nurse practitioner scope of practice.
DC's professional corporation ownership rules (DC Code §§ 29-508, 29-511) are among the strictest in the country for equity participation in the clinical entity, so telehealth and medspa operators should have DC health-law counsel review any PC-MSO structure before launch, with particular attention to management-fee methodology and clinical-control provisions. DC participates in the Interstate Medical Licensure Compact and other compacts that can streamline physician licensure. Informed consent and standard-of-care documentation equivalent to an in-person visit are required for all telehealth encounters.
The Health Occupations Revision General Amendment Act (B25-0545), enacted 2023–2024, repealed the collaboration/protocol requirements for APRNs, formalizing full independent practice authority for nurse practitioners in the District. Federal DEA telemedicine flexibilities for controlled-substance prescribing have been extended four times since 2023 and currently expire December 31, 2026.
Our providers see your patients — full clinical encounters with prescribing authority, not rubber-stamp clearance visits.
A board-certified physician licensed in your states takes the medical director role under our medical group — protocols, provider oversight and chart review included. Part of onboarding, never a name rented for a filing.
We pair your NPs and PAs with collaborating physicians for compliant prescribing and clinical oversight.
State-aware CPOM implementation support coordinated with the operator's independent legal counsel.
Physician-led chart reviews that surface documentation gaps against current state requirements.
Receive instant notifications when District of Columbia changes healthcare regulations.
Subscribe to AlertsTake the free assessment (about 3-5 minutes). We'll score your CPOM, prescribing, and licensing gaps and tell you what to fix first.